Maiko Maruyama-Inoue
10PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Mar 03, 2026
Comparison of Short-term Outcomes Between Faricimab and High-Dose Aflibercept in Patients With Neovascular Age-related Macular Degeneration.Mizuho Shiratori, Maiko Maruyama-Inoue, Yasuo Yanagi
|Jul 23, 2025
One-Year Outcomes of Intravitreal Faricimab Injection in Treatment-Naïve Patients With Neovascular Age-Related Macular Degeneration.Kazuyoshi Okawa, Maiko Maruyama-Inoue, Jacob Yuhang Chin
|Apr 14, 2025
Three-year visual outcomes after brolucizumab in patients with neovascular age-related macular degeneration.Yume Kobayashi, Maiko Maruyama-Inoue, Tatsuya Inoue
|Mar 17, 2025
Comparison Between Intravitreal Anti-Vascular Endothelial Growth Factor Monotherapy and Vitrectomy in Age-Related Macular Degeneration with Large Submacular Hemorrhages.Misa Miyazato, Maiko Maruyama-Inoue, Shin Tanaka
|Nov 25, 2024
Importance of fluorescein angiography as a predictor of treatment response in patients with pachychoroid neovasculopathy.Maiko Maruyama-Inoue, Yasuo Yanagi, Tatsuya Inoue
|Apr 18, 2024
Visual outcomes of intraocular inflammation after brolucizumab injection in Japanese patients with neovascular age-related macular degeneration.Kazushi Hirono, Maiko Maruyama-Inoue, Yasuo Yanagi
Pageof 2
